Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Celldex Therapeutics Inc’s current trading price is -54.52% away from its 52-week high, while its distance from the 52-week low is 48.44%. The stock’s price range over this period has fluctuated between $14.40 and $47.00. The company, operating within the financial sector, had a trading volume of approximately 1.56 million for the day, which was noticeably higher than the average daily share volume of 0.89 million over the last 3 months.
In terms of market performance, Celldex Therapeutics Inc had a fairly uneven.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Celldex Therapeutics Inc (CLDX) has experienced a quarterly rise of 4.68% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.42B and boasts a workforce of 186 employees.
Analyzing Trading Volume and Moving Average Trends
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CLDX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
CLDX Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price decrease of -15.41%. However, over the past six months, we’ve seen a stronger performance of -19.37%. The price of CLDX fallen by 12.86% over the last 30 days. And in the last five days, it has surged by 0.12%.
